Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?

Albemarle is set to release its first-quarter 2026 earnings report on May 6. Here’s Morningstar’s take on what to look for in Albemarle’s earnings and the outlook for its stock.

Key Morningstar Metrics for Albemarle

• Fair Value Estimate
  : $200.00
• Morningstar Rating
  : ★★★
• Morningstar Economic Moat Rating
  : Narrow
• Morningstar Uncertainty Rating
  : Very High

Albemarle Earnings Release Date

• Wednesday, May 6, after the close of trading

What to Watch for in Albemarle’s Q1 Earnings

• We will be looking for Albemarle’s realized lithium prices. Based on published indexes, lithium spot prices rose significantly during the quarter. We’ll also see management’s outlook for prices during the second quarter and the remainder of 2026.
• We will be watching the firm’s volume growth. Management is finishing boosting new capacity, so we will see whether Albemarle’s new plants are ramping up on schedule and if they’ll be running near full capacity by the end of the year.
• We will have an eye on Albemarle’s realized unit production costs. As the company augments its new plants, management guidance called for falling unit production costs excluding royalties and export taxes, which are tied to realized prices. We believe Albemarle will realize lower unit production costs excluding royalties and export taxes in 2026 versus 2025, so we will see if our prediction is on track.
• We hope to hear an update on management’s investment strategy. In response to falling prices, Albemarle greatly reduced its capital expenditures and halted most growth plans. Management said it would take a more disciplined capital allocation approach after prices recovered. So, we will see how management is approaching growth investment following price increases.

Fair Value Estimate for Albemarle

With its 3-star rating, we believe Albemarle’s stock is fairly valued compared with our long-term fair value estimate of $200. We maintain our $200 fair value estimate for Albemarle following the company’s fourth-quarter earnings. We assume roughly a 10% weighted average cost of capital. We use a multiple of 11.5 times midcycle EBITDA to value free cash flows generated beyond our 10-year explicit forecast horizon.

Read more about Albemarle’s fair value estimate.

Economic Moat Rating

We award Albemarle a narrow moat for its strong and durable cost advantage in lithium and bromine production. Albemarle has a cost advantage in lithium carbonate production, thanks to its lucrative brine assets in Chile’s Salar de Atacama, which produce lithium at the lowest cost globally. Albemarle’s advantaged position in bromine comes from its low-cost and long-lived assets in the Dead Sea and Arkansas. In all, we think Albemarle’s strong and durable cost advantage in lithium and bromine makes it more likely than not that the company will outearn its cost of capital over at least the next decade.

Read more about Albemarle’s economic moat.

Financial Strength

Albemarle is currently in decent financial health. As of Dec. 31, management reported net debt/adjusted EBITDA was 2 times, within management’s long-term target of less than 2.5. We expect adjusted EBITDA to rise in the coming quarters due to higher lithium prices. In 2025, despite cyclically low lithium prices, Albemarle generated positive free cash flow exceeding dividends. As EBITDA and free cash flow grow, we think the company will also pay down debt. Additionally, Albemarle will divest a 51% stake in Ketjen, its catalysts business, to KPS, for $660 million before taxes and fees in a deal that should close in 2026. These funds should support the balance sheet.

Read more about Albemarle’s financial strength.

Risk and Uncertainty

We assign Albemarle a Very High Morningstar Uncertainty Rating. The biggest risk for Albemarle is volatile lithium prices. Prices could decline if demand grows more slowly than expected due to slowing EV sales growth, or if producers bring too much supply to the market. New batteries, such as sodium-ion, could overtake lithium as the preferred energy storage resource. New lithium production technologies could also alter the cost curve, such as direct lithium extraction.

Albemarle faces execution risk in ramping up its new lithium projects, including production delays and cost overruns. Albemarle is also subject to political risk in Chile. President Gabriel Boric wants the Chilean government to own a majority stake in all projects. If this occurs, Albemarle could be forced to trade a 50.1% stake to the Chilean government to extend its lease when it expires in 2043.

The largest ESG risks come from potential new regulations. Regulations could limit emissions in the bromine business, and the company may not be able to pass along the cost increases. We see this as having a moderate probability and materiality. Another risk is that Albemarle may have its products banned due to their environmental impact, which has occurred before in the bromine business. We see a moderate probability but a low materiality as Albemarle doesn’t rely on a single product and could likely modify its products to meet new regulations. If Albemarle is forced to reduce its emissions, all lithium producers would be subject to the same requirements, so the company could likely pass along these costs.

Read more about Albemarle’s risk and uncertainty.

ALB Bulls Say

• Albemarle has top-tier lithium assets through its brine operations in Chile and spodumene hard-rock operations in Western Australia, which are among the lowest-cost sources of lithium production globally.
• Lithium prices will rebound and then remain well above the marginal cost of production through at least the remainder of the decade, leading to excess profits and return on invested capital for Albemarle.
• Albemarle has low-cost bromine production through its highly concentrated brines in the Dead Sea and Arkansas.

ALB Bears Say

• Lithium prices will fall and remain lower for longer as new supply growth will outpace demand, weighing on profitability.
• Albemarle’s investment in higher-cost lithium resources, including Wogdina and King’s Mountain, will prove value-destructive as they will not generate returns above its weighted average cost of capital.
• Chile’s plan to nationalize lithium could force Albemarle to trade a majority stake to the government to renew its lease, destroying shareholder value.

This article was compiled by Jillian Moore.